JPWO2021048638A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021048638A5
JPWO2021048638A5 JP2022515997A JP2022515997A JPWO2021048638A5 JP WO2021048638 A5 JPWO2021048638 A5 JP WO2021048638A5 JP 2022515997 A JP2022515997 A JP 2022515997A JP 2022515997 A JP2022515997 A JP 2022515997A JP WO2021048638 A5 JPWO2021048638 A5 JP WO2021048638A5
Authority
JP
Japan
Prior art keywords
diameter
droplets
range
pharmaceutical composition
ranging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022515997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022548233A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/051882 external-priority patent/WO2021048638A1/fr
Publication of JP2022548233A publication Critical patent/JP2022548233A/ja
Publication of JPWO2021048638A5 publication Critical patent/JPWO2021048638A5/ja
Pending legal-status Critical Current

Links

JP2022515997A 2019-09-13 2020-03-04 エスケタミンの鼻腔内投与 Pending JP2022548233A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962899870P 2019-09-13 2019-09-13
US62/899,870 2019-09-13
PCT/IB2020/051882 WO2021048638A1 (fr) 2019-09-13 2020-03-04 Administration intranasale d'eskétamine

Publications (2)

Publication Number Publication Date
JP2022548233A JP2022548233A (ja) 2022-11-17
JPWO2021048638A5 true JPWO2021048638A5 (fr) 2023-03-07

Family

ID=74866204

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022515997A Pending JP2022548233A (ja) 2019-09-13 2020-03-04 エスケタミンの鼻腔内投与

Country Status (11)

Country Link
US (3) US20220339123A1 (fr)
EP (1) EP4028085A4 (fr)
JP (1) JP2022548233A (fr)
KR (1) KR20220079859A (fr)
CN (1) CN115135363A (fr)
AU (1) AU2020345050A1 (fr)
BR (1) BR112022004497A2 (fr)
CA (1) CA3153856A1 (fr)
IL (1) IL291273A (fr)
MX (1) MX2022003134A (fr)
WO (1) WO2021048638A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020345050A1 (en) * 2019-09-13 2021-09-16 Janssen Pharmaceuticals, Inc. Intranasal administration of esketamine
WO2023131922A1 (fr) * 2022-01-10 2023-07-13 Janssen Pharmaceuticals, Inc. Compositions et méthodes de traitement de la dépression
AU2023206048A1 (en) * 2022-01-10 2024-08-29 Janssen Pharmaceuticals, Inc. Compositions and methods for the treatment of depression

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS4516A (is) * 1997-07-01 1999-01-02 Gizurarson Sveinbjörn Nýtt lyfjaform
GB9806939D0 (en) * 1998-03-31 1998-05-27 Procter & Gamble A spray device
CN103619485B (zh) * 2011-05-09 2017-08-08 英倍尔药业股份有限公司 用于鼻腔药物递送的喷嘴
WO2013138322A1 (fr) * 2012-03-12 2013-09-19 Janssen Pharmaceutica Nv Eskétamine dans le traitement de la dépression réfractaire ou résistante aux traitements
CN105073103A (zh) * 2013-03-15 2015-11-18 詹森药业有限公司 S-盐酸氯胺酮的药物组合物
DE102013019441B4 (de) * 2013-11-21 2024-03-28 Justus-Liebig-Universität Giessen Zerstäubersystem und dessen Verwendung
US10441538B2 (en) * 2014-07-08 2019-10-15 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
SG11202005896WA (en) * 2017-12-22 2020-07-29 Janssen Pharmaceuticals Inc Esketamine for the treatment of depression
MX2021010683A (es) * 2019-03-05 2021-12-10 Janssen Pharmaceuticals Inc Esketamina para el tratamiento de la depresión.
AU2020345050A1 (en) * 2019-09-13 2021-09-16 Janssen Pharmaceuticals, Inc. Intranasal administration of esketamine

Similar Documents

Publication Publication Date Title
US9381349B2 (en) Apparatus for treating cerebral neurovascular disorders including headaches by neural stimulation
ES2707548T3 (es) Administración de treprostinil utilizando un inhalador de dosis medida
US20050281751A1 (en) Directed intranasal administration of pharmaceutical agents
US10016582B2 (en) Circumferential aerosol device
US6491940B1 (en) Apparatus for administering composition for inhibiting cerebral neurovascular disorders and muscular headaches
US20240108627A1 (en) Phosphodiesterase Inhibitor Treatment
US20180235934A1 (en) Noradrenergic drug treatment of obstructive sleep apnea
US20210401740A1 (en) Method and system for the treatment of chronic copd with nebulized anticholinergic administrations
KR20170023092A (ko) 의료용 주사기에 이용되는 비강 분무 노즐
US8709496B2 (en) Use of deuterium oxide for the treatment of virus-based diseases of the respiratory tract
US11759586B1 (en) Nasal spray bottle with improved nozzle and system of application
RU2008135580A (ru) Альфа-1-антитрипсин для лечения эпизодов воспаления болезней легких
JP2024531784A (ja) トブラマイシン吸入溶液を含む薬学的組立品及びその使用
JPWO2021048638A5 (fr)
Illum Intranasal delivery to the central nervous system
Suryawanshi et al. Efficacy of preoperative dexmedetomidine nebulization on blunting the hemodynamic response to laryngoscopy and intubation
US20060183767A1 (en) Methods of stimulating immune response in certain individuals
US20120244213A1 (en) Methods for the treatment of speech impediments
CN209005028U (zh) 一种鼻炎药剂瓶收纳及给药装置
US9889109B2 (en) Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
CN219517430U (zh) 一种精准鼻嗅区喷射的装置
Khawaja et al. Development and Patient Experience Evaluation of a Gentle Atomizer for Nasal Drug Delivery
CN116392708B (zh) 一种可持续释放一氧化氮的药物组件及其用途
JPWO2020247127A5 (fr)
JPWO2021194893A5 (fr)